If you fail to reproduce another scientist’s results, this journal wants to know | Science | AAAS

"The biotech company Amgen Inc. and prominent biochemist Bruce Alberts have created a new online journal that aims to lift the curtain on often hidden results in biomedicine: failed efforts to confirm other groups’ published papers. Amgen is seeding the publication with reports on its own futile attempts to replicate three studies in diabetes and neurodegenerative disease and hopes other companies will follow suit. The contradictory results—along with successful confirmations—will be published by F1000Research, an open-access, online-only publisher ..."